Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration

Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with prostate cancer

Features	No. of patients	PSMC2 expression		P value
Features	No. of patients	Low	High	P value
All cases	152	82	70
Age (years)				0.272
≤ 69	79	46	33
> 69	73	36	37
Gleason score				0.031*
≤ 8	89	53	36
> 8	56	23	33
T infiltrate				0.420
T1	2	2	0
T2	68	39	29
T3	37	18	19
T4	6	4	2
Lymphatic metastasis (N)				0.735
N0	105	59	46
N1	8	4	4
Stage				0.077
I	14	13	1
II	56	28	28
III	31	16	15
IV	12	6	6
Gleason grade				< 0.001***
2	8	7	1
3	38	26	12
4	51	26	25
5	47	17	30

ISSN: 1475-2867